ALKERMES | ALKS - Ebit

股票价格

37.55

每天变化

-0.81 -2.11%

每月一次

11.21%

每年

19.51%

Q2 预测

33.96

金融业

USD

USD 4.26B

现金及等价物

USD 351.55M

USD 73.25M

USD 1.36B

USD 599.5M

USD 1.58B

股息收益率

0

USD -48.28M

USD 80.26M

1.8K

EPS每股收益

USD -0.4

股本和储备

USD 1.75B

USD 331.33M

债务利息支出

USD 20.89M

USD 8.54M

USD 1.48B

USD 6.21B

USD -66.48M

USD 1.75B

USD -48.28M

普通股股本

USD 166.46M

39.33

USD -61.93M

USD 392.91M

销售和管理费用

USD 264.59M

USD 336.7M

贸易债权人

USD 102.36M

应收帐款人

USD 407.63M

	Ebit	更改		日
AbbVie	USD 4.73B		1.08B	2026-03
Acadia Pharmaceuticals	USD -4.62M		22.01M	2026-03
ALKERMES	USD -48.28M		37.33M	2026-03
Amgen	USD 3.83B		130M	2026-03
Biogen	USD 514.3M		502.8M	2026-03
BioMarin Pharmaceutical	USD 129.65M		68.74M	2026-03
Bristol-Myers Squibb	USD 3.56B		90M	2026-03
Coherus Biosciences	USD -39.08M		3.65M	2025-12
Eli Lilly	USD 9.78B		792M	2026-03
Gilead Sciences	USD 2.68B		284M	2026-03
Heron Therapeutics	USD 38K		3.83M	2025-12
Ionis Pharmaceuticals	USD -118M		97M	2026-03
J&J	USD 6.62B		1.51B	2026-03
Malin Corporation	EUR -1.1M		300K	2024-12
Merck	USD -1.88B		8.12B	2026-03
Minerva Neurosciences	USD -4.37M		1.71M	2024-09
Nektar Therapeutics	USD -19.09M		15.26M	2025-12
Neurocrine Biosciences	USD 214.6M		13.3M	2026-03
Otsuka Holdings	JPY 118.21B		50.97B	2026-03
Ovoca Bio	EUR -1.16M		4.48M	2025-06
Pfizer	USD 4.99B		340M	2026-03
Regeneron Pharmaceuticals	USD 744.8M		153.8M	2026-03
Vertex Pharmaceuticals	USD 1.14B		124.5M	2026-03